ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Cross Above Fifty Day Moving Average – Should You Sell?

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) shares crossed above its 50 day moving average during trading on Friday. The stock has a 50 day moving average of $113.47 and traded as high as $118.03. ProShares Ultra Nasdaq Biotechnology shares last traded at $117.7660, with a volume of 5,877 shares.

ProShares Ultra Nasdaq Biotechnology Stock Up 4.5%

The stock has a market capitalization of $101.28 million, a price-to-earnings ratio of 20.68 and a beta of 1.25. The business’s 50 day simple moving average is $113.47 and its 200-day simple moving average is $95.82.

Shares of ProShares Ultra Nasdaq Biotechnology are set to split before the market opens on Thursday, November 19th. The 2-1 split was recently announced. The newly issued shares will be issued to shareholders after the market closes on Wednesday, November 18th.

Institutional Trading of ProShares Ultra Nasdaq Biotechnology

Large investors have recently made changes to their positions in the company. Kaizen Financial Strategies lifted its holdings in shares of ProShares Ultra Nasdaq Biotechnology by 4.7% in the first quarter. Kaizen Financial Strategies now owns 5,565 shares of the exchange traded fund’s stock worth $483,000 after acquiring an additional 250 shares during the last quarter. Toth Financial Advisory Corp acquired a new stake in shares of ProShares Ultra Nasdaq Biotechnology in the 3rd quarter valued at approximately $118,000. Finally, Capital Investment Advisors LLC bought a new stake in shares of ProShares Ultra Nasdaq Biotechnology during the 3rd quarter valued at approximately $658,000.

About ProShares Ultra Nasdaq Biotechnology

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day.